Veru
VERU
130 hedge funds and large institutions have $23.3M invested in Veru in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 30 reducing their positions, and 11 closing their positions.
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
57% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 30
6% more funds holding
Funds holding: 123 → 130 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.7% less ownership
Funds ownership: 3.95% → 3.25% (-0.7%)
38% less capital invested
Capital invested by funds: $37.6M → $23.3M (-$14.3M)
86% less call options, than puts
Call options by funds: $255K | Put options by funds: $1.77M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$1.43M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$941K |
| 3 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$341K |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$298K |
| 5 |
BlackRock
New York
|
+$209K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$4.22M |
| 2 |
Millennium Management
New York
|
-$2.32M |
| 3 |
ACM
Altium Capital Management
New York
|
-$1.32M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$806K |
| 5 |
EAM
Exome Asset Management
New York
|
-$693K |
VERU Hedge Fund Activity: Q1 2025 in Review
130 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Veru (VERU) for Q1 2025, worth a combined $23.3M — down 38% from $37.6M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new VERU positions and 11 closed out — a net gain of 7 holders — while 47 added to existing stakes and 30 trimmed.
The largest buyer was MPM BioImpact, adding an estimated $1.43M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $4.22M sold.
- 130 institutional investors held Veru (VERU) as of Q1 2025, up from 123 in Q4 2024.
- Funds reported $23.3M of Veru stock for Q1 2025, down 38% quarter-over-quarter.
- 18 funds opened new Veru positions in Q1 2025 and 11 closed out, a net change of +7 holders.
- The largest Veru buyer in Q1 2025 was MPM BioImpact, an estimated $1.43M added.
- The largest Veru seller in Q1 2025 was Perceptive Advisors, an estimated $4.22M sold.
Based on aggregated 13F filings for Q1 2025.